A bottom-line case for moving your lens finishing in-house

Article

Spectacle lens sales, excluding frames, generate about the same annual revenue as eye exams, yet are often an afterthought for many busy practices.

Spectacle lens sales, excluding frames, generate about the same annual revenue as eye exams, yet are often an afterthought for many busy practices. Adding in-office finishing can help maximize revenues, Mike Rothschild, OD, said.

Although two-thirds of patients see an optometrist for eye exams, three or four out of every 10 leave the office to purchase eyewear elsewhere, according to Dr. Rothschild. "In a practice with $750,000 annual gross revenue and an average eyewear capture rate of 61%, $160,000 in revenue walks out the door each year," he said.

Factors to consider

Compare the costs of the outsourcing business model to those of the in-office model by calculating monthly outsourcing costs, in-office finishing costs, insurance reimbursements, and in-office finishing savings. The result will be an estimate of the annual margin from in-office finishing.

In the financial analysis, remember to balance the cost of a major purchase, such as an edger, with new revenue. But generating that new revenue will cost money, and the formula doesn't work if both inputs are equal. Dr. Rothschild recommended that you plan to generate up to twice as much revenue as any new expense-$1,500 to $2,000 in revenue for a $1,000 cost.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.